Intelligence · Clinical Development
Pipeline search results
Programs matching “Vertex Pharmaceuticals” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 159 pipeline programs matching "Vertex Pharmaceuticals" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
VX-765
Vertex Pharmaceuticals (Australia) Pty.
Partial Epilepsy
1 trial -
VX-765 Part A
Vertex Pharmaceuticals (Australia) Pty.
Epilepsy
1 trial -
VX-770
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
3 trials -
VX-787
Vertex Pharmaceuticals (Australia) Pty.
Influenza Virus
1 trial -
VX-814
Vertex Pharmaceuticals (Australia) Pty.
Alpha 1-Antitrypsin Deficiency
1 trial -
VX-864
Vertex Pharmaceuticals (Australia) Pty.
Alpha-1 Antitrypsin Deficiency
1 trial -
VX-864
Vertex Pharmaceuticals (Australia) Pty.
Alpha1-Antitrypsin Deficiency
1 trial -
VX-950
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
2 trials -
VX-993
Vertex Pharmaceuticals (Australia) Pty.
Acute Pain
1 trial -
VX-993
Vertex Pharmaceuticals (Australia) Pty.
Diabetic Peripheral Neuropathic Pain
1 trial -
VX23-670-001
Vertex Pharmaceuticals (Australia) Pty.
Myotonic Dystrophy
1 trial -
VX24-993-103
Vertex Pharmaceuticals (Australia) Pty.
Pain Associated With Diabetic Peripheral Neuropathy
1 trial -
biricodar dicitrate
Vertex Pharmaceuticals (Australia) Pty.
Lung Cancer
1 trial -
telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C Virus Infection
1 trial -
telaprevir or matching placebo
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
14C-VX-993
Vertex Pharmaceuticals (Australia) Pty.
Pain
1 trial -
ALS-002158
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C, Chronic
1 trial -
ALS-002200
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C, Chronic
1 trial -
AVN-944 capsules for oral administration
Vertex Pharmaceuticals (Australia) Pty.
Acute Leukemia
1 trial -
G060-A5
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
IXP
Vertex Pharmaceuticals (Australia) Pty.
Renal Impairment
1 trial -
IXP
Vertex Pharmaceuticals (Australia) Pty.
Focal Segmental Glomerulosclerosis (FSGS)
1 trial -
MP-424 (Telaprevir)
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial -
PegInterferon
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.